+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Stent Grafts Market 2020-2024

  • PDF Icon

    Report

  • 120 Pages
  • February 2020
  • Region: Global
  • TechNavio
  • ID: 4990996
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Stent Grafts Market 2020-2024

The publisher has been monitoring the global stent grafts market and it is poised to grow by USD 838.38 mn during 2020-2024, progressing at a CAGR of 5% during the forecast period. The report on the global stent grafts market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of aortic aneurysms and co-morbidities.In addition, growing preference for minimally invasive surgeries is anticipated to boost the growth of the global stent grafts market as well.

Market Segmentation

The global stent grafts market is segmented as below:

Product:
  • Coronary Stent Grafts
  • Peripheral Stent Grafts

Geographic Segmentation:
  • Asia
  • Europe
  • North America
  • ROW

Key Trends for the global stent grafts market growth

This study identifies growing preference for minimally invasive surgeries as the prime reasons driving the global stent grafts market growth during the next few years.

Prominent vendors in the global stent grafts market

The publisher provides a detailed analysis of around 25 vendors operating in the global stent grafts market, including some of the vendors such as Becton, Dickinson and Co., Cardinal Health Inc., Cook Group Inc., CryoLife Inc., Endologix Inc., Endospan Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp. and W. L. Gore & Associates Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$

03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Coronary stent grafts - Market size and forecast 2019-2024
  • Peripheral stent grafts - Market size and forecast 2019-2024
  • Market opportunity by product

07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

09: DECISION FRAMEWORK
10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges

11: MARKET TRENDS
  • Growing number of strategic alliances
  • Growing preference for minimally invasive surgeries
  • Technological advances and rising number of breakthrough
  • device designations

12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario

13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Becton, Dickinson and Co.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • CryoLife Inc.
  • Endologix Inc.
  • Endospan Ltd.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Terumo Corp.
  • W. L. Gore & Associates Inc.

14: APPENDIX
  • Research methodology
  • List of abbreviations
Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key product offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Coronary stent grafts - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Coronary stent grafts - Year-over-year growth 2020-2024 (%)
Exhibit 22: Peripheral stent grafts - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Peripheral stent grafts - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details
Exhibit 39: M&A and their market impact analysis
Exhibit 40: Product recalls: Overview
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Type of strategic alliances
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Becton, Dickinson and Co. - Vendor overview
Exhibit 49: Becton, Dickinson and Co. - Business segments
Exhibit 50: Becton, Dickinson and Co. - Organizational developments
Exhibit 51: Becton, Dickinson and Co. - Geographic focus
Exhibit 52: Becton, Dickinson and Co. - Segment focus
Exhibit 53: Becton, Dickinson and Co. - Key offerings
Exhibit 54: Becton, Dickinson and Co. - Key customers
Exhibit 55: Cardinal Health Inc. - Vendor overview
Exhibit 56: Cardinal Health Inc. - Business segments
Exhibit 57: Cardinal Health Inc. - Organizational developments
Exhibit 58: Cardinal Health Inc. - Geographic focus
Exhibit 59: Cardinal Health Inc. - Segment focus
Exhibit 60: Cardinal Health Inc. - Key offerings
Exhibit 61: Cardinal Health Inc. - Key customers
Exhibit 62: Cook Group Inc. - Vendor overview
Exhibit 63: Cook Group Inc. - Product segments
Exhibit 64: Cook Group Inc. - Organizational developments
Exhibit 65: Cook Group Inc. - Key offerings
Exhibit 66: Cook Group Inc. - Key customers
Exhibit 67: CryoLife Inc. - Vendor overview
Exhibit 68: CryoLife Inc. - Business segments
Exhibit 69: CryoLife Inc. - Organizational developments
Exhibit 70: CryoLife Inc. - Geographic focus
Exhibit 71: CryoLife Inc. - Segment focus
Exhibit 72: CryoLife Inc. - Key offerings
Exhibit 73: CryoLife Inc. - Key customers
Exhibit 74: Endologix Inc. - Vendor overview
Exhibit 75: Endologix Inc. - Business segments
Exhibit 76: Endologix Inc. - Organizational developments
Exhibit 77: Endologix Inc. - Geographic focus
Exhibit 78: Endologix Inc. - Key offerings
Exhibit 79: Endologix Inc. - Key customers
Exhibit 80: Endospan Ltd. - Vendor overview
Exhibit 81: Endospan Ltd. - Business segments
Exhibit 82: Endospan Ltd. - Organizational developments
Exhibit 83: Endospan Ltd. - Key offerings
Exhibit 84: Endospan Ltd. - Key customers
Exhibit 85: Medtronic Plc - Vendor overview
Exhibit 86: Medtronic Plc - Business segments
Exhibit 87: Medtronic Plc - Organizational developments
Exhibit 88: Medtronic Plc - Geographic focus
Exhibit 89: Medtronic Plc - Segment focus
Exhibit 90: Medtronic Plc - Key offerings
Exhibit 91: Medtronic Plc - Key customers
Exhibit 92: MicroPort Scientific Corp. - Vendor overview
Exhibit 93: MicroPort Scientific Corp. - Business segments
Exhibit 94: MicroPort Scientific Corp. - Organizational developments
Exhibit 95: MicroPort Scientific Corp. - Geographic focus
Exhibit 96: MicroPort Scientific Corp. - Segment focus
Exhibit 97: MicroPort Scientific Corp. - Key offerings
Exhibit 98: MicroPort Scientific Corp. - Key customers
Exhibit 99: Terumo Corp. - Vendor overview
Exhibit 100: Terumo Corp. - Business segments
Exhibit 101: Terumo Corp. - Organizational developments
Exhibit 102: Terumo Corp. - Geographic focus
Exhibit 103: Terumo Corp. - Segment focus
Exhibit 104: Terumo Corp. - Key offerings
Exhibit 105: Terumo Corp. - Key customers
Exhibit 106: W. L. Gore & Associates Inc. - Vendor overview
Exhibit 107: W. L. Gore & Associates Inc. - Product segments
Exhibit 108: W. L. Gore & Associates Inc. - Organizational developments
Exhibit 109: W. L. Gore & Associates Inc. - Key offerings
Exhibit 110: W. L. Gore & Associates Inc. - Key customers
Exhibit 111: Validation techniques employed for market sizing
Exhibit 112: Definition of market positioning of vendors

Executive Summary

The publisher recognizes the following companies as the key players in the global stent grafts market :Becton, Dickinson and Co., Cardinal Health Inc., Cook Group Inc., CryoLife Inc., Endologix Inc., Endospan Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp. and W. L. Gore & Associates Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing preference for minimally invasive surgeries"

According to the report, one of the major drivers for this market is the increasing prevalence of aortic aneurysms and co-morbidities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton
  • Dickinson and Co.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • CryoLife Inc.
  • Endologix Inc.
  • Endospan Ltd.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Terumo Corp.
  • W. L. Gore & Associates Inc.